MedTrace Logo

Puerto Rico COVID-19 Vaccine Uptake Study

NCT05468021 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 394

Last updated 2022-12-16

No results posted yet for this study

Summary

The purpose of this study is to recruit a total of 386 participants to evaluate the effectiveness of an educational program to increase the proportion of men and women aged 21 years and older who have received the COVID-19 booster vaccine

Conditions

Interventions

OTHER

Educational intervention

Randomized Clinical Trial (study design) to evaluate the effectiveness of an educational intervention to increase vaccine uptake among socioeconomically disadvantaged adults. The intervention will consist of a health promoter with an educational toolkit addressing misinformation, distrust, and hesitancy regarding the COVID-19 vaccine. An educational website with videos addressing COVID-19 vaccine will be available to study participants to boost information provided in the educational toolkit.

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Institute on Minority Health and Health Disparities (NIMHD)

    collaborator NIH

  • University of Puerto Rico

    lead OTHER

Principal Investigators

  • Emma Fernandez-Repollet, Ph D · Deanship of Academic Affairs RCMI Center for Collaborative Research in Health Disparities

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-26
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • Puerto Rico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05468021 on ClinicalTrials.gov